↓ Skip to main content

Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines

Overview of attention for article published in Journal of Translational Medicine, September 2008
Altmetric Badge

Citations

dimensions_citation
72 Dimensions

Readers on

mendeley
60 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines
Published in
Journal of Translational Medicine, September 2008
DOI 10.1186/1479-5876-6-53
Pubmed ID
Authors

Alex J Eustace, John Crown, Martin Clynes, Norma O'Donovan

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 3%
United Kingdom 1 2%
Portugal 1 2%
Unknown 56 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 13 22%
Student > Bachelor 9 15%
Student > Ph. D. Student 8 13%
Student > Master 4 7%
Professor 2 3%
Other 5 8%
Unknown 19 32%
Readers by discipline Count As %
Agricultural and Biological Sciences 14 23%
Biochemistry, Genetics and Molecular Biology 12 20%
Medicine and Dentistry 3 5%
Pharmacology, Toxicology and Pharmaceutical Science 2 3%
Business, Management and Accounting 2 3%
Other 7 12%
Unknown 20 33%